ArticleClinical rheumatology2022

Improvement in disease activity among patients with rheumatoid arthritis who switched from intravenous infliximab to intravenous golimumab in the ACR RISE registry.

John Tesser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.